Ascentage Pharma Group International (AAPG)
NASDAQ: AAPG · Real-Time Price · USD
18.56
-0.94 (-4.82%)
May 18, 2026, 4:00 PM EDT - Market closed
AAPG Stock Forecast
Stock Price Forecast
According to 8 analysts polled by S&P Global, AAPG stock has a consensus rating of "Strong Buy" and an average price target of $7.03. The average 1-year stock price forecast is 62.12% lower than the current stock price, while the lowest is $5.87 (-68.37%) and the highest is $8.08 (-56.47%).
Price Target: $7.03 (-62.12%)
Analyst Consensus: Strong Buy
* Price targets were last updated on Apr 13, 2026.
Analyst Ratings
The average analyst rating for AAPG stock is "Strong Buy". This means that analysts believe this stock is likely to perform very well in the near future and significantly outperform the market.
Recommendation Trends
| Rating | Dec '25 | Jan '26 | Feb '26 | Mar '26 | Apr '26 | May '26 |
|---|---|---|---|---|---|---|
| Strong Buy | 2 | 2 | 2 | 3 | 3 | 3 |
| Buy | 3 | 3 | 3 | 3 | 2 | 2 |
| Hold | 0 | 0 | 0 | 0 | 0 | 0 |
| Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Strong Sell | 0 | 0 | 0 | 0 | 0 | 0 |
| Total | 5 | 5 | 5 | 6 | 5 | 5 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| BTIG | BTIG | Strong Buy Reiterates $48 | Strong Buy | Reiterates | $48 | +158.62% | Apr 13, 2026 |
| BTIG | BTIG | Strong Buy Reiterates $48 | Strong Buy | Reiterates | $48 | +158.62% | Mar 26, 2026 |
| BTIG | BTIG | Strong Buy Initiates $48 | Strong Buy | Initiates | $48 | +158.62% | Mar 12, 2026 |
| Oppenheimer | Oppenheimer | Buy Initiates $45 | Buy | Initiates | $45 | +142.46% | Dec 4, 2025 |
| Truist Securities | Truist Securities | Strong Buy Initiates $51 | Strong Buy | Initiates | $51 | +174.78% | Nov 24, 2025 |
Financial Forecast
Revenue This Year
2.03B
from 574.12M
Increased by 253.76%
Revenue Next Year
2.01B
from 2.03B
Decreased by -0.89%
EPS This Year
0.43
from -3.49
EPS Next Year
-0.17
from 0.43
Financial currency is CNY. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 3.3B | 3.2B | ||||||
| Avg | 2.0B | 2.0B | ||||||
| Low | 829.1M | 1.0B |
Revenue Growth
| Revenue Growth | 2026 | 2027 | 2028 | 2029 | 2030 | 2031 | 2032 | 2033 |
|---|---|---|---|---|---|---|---|---|
| High | 477.2% | 56.8% | ||||||
| Avg | 253.8% | -0.9% | ||||||
| Low | 44.4% | -50.3% |
EPS Forecast
| EPS | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | 4.84 | 3.44 | |||
| Avg | 0.43 | -0.17 | |||
| Low | -2.98 | -1.73 |
EPS Growth
| EPS Growth | 2026 | 2027 | 2028 | 2029 | 2030 |
|---|---|---|---|---|---|
| High | - | 710.2% | |||
| Avg | - | - | |||
| Low | - | - |
Sources: Price targets and consensus ratings provided by S&P Global Market Intelligence. Historical ratings and analyst data provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data sources.